Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
Clinical trial NCT07349160 · RECRUITING
Trial details
- NCT number
- NCT07349160
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-10
- Primary completion
- 2027-03-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.